Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 13 entities : Beigene, ltd. save search
Amgen To Showcase New Data From Inflammation Portfolio At EADV Virtual Congress 2021
Published: 2021-09-13 (Crawled : 14:00) - biospace.com/
BGNE | $131.15 1.26% 1.24% 150K
|
Health Technology
|
| O: 0.0%
H: 4.26%
C: 3.47%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: 1.55%
H: 0.92%
C: -0.16%
Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress
Published: 2021-09-13 (Crawled : 14:00) - biospace.com/
LPTX | $3.17 13.21% 11.67% 330K
|
Health Technology
|
| O: 28.08%
H: 2.67%
C: -5.35%
BGNE | $131.15 1.26% 1.24% 150K
|
Health Technology
|
| O: 0.0%
H: 4.26%
C: 3.47%
BeiGene Announces U.S. FDA Acceptance of Biologics License Application for Tislelizumab in Esophageal Squamous Cell Carcinoma
Published: 2021-09-13 (Crawled : 07:00) - biospace.com/
BGNE | $131.15 1.26% 1.24% 150K
|
Health Technology
|
| O: 0.0%
H: 4.26%
C: 3.47%
fda fda acceptance license application cell carcinoma
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.